NeoGenomics

NEOGENOMICS INC

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.


Those subscribing to a momentum investing strategy tend to believe that stocks experiencing price increases tend to rally, so long as both internal and external conditions don&#39;t change. Of course, no rally can continue

It&#39;s Not Too Late to Jump on These Under-the-Radar Momentum Plays

nike shutter2

News

Downgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

PCAR

QTRX

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Bangkok,thailand,-,January,28,2015:,Visa,Credit,Cards,On,Leather,Board.

Price Target

ABNB

ATRC

SBUX

TMUS

WRBY

ZYXI

Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

NeoGenomics Inc

Neo - United States Dollar

Neogen Corp

NeoJapan Inc

NEOMEDIA TECHS INC by NeoMedia Technologies, Inc.

NeoMedia Technologies Inc

Neonode Inc

Neon - United States Dollar

NEO - TrueUSD

NeoVolta Inc

Press Releases

NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

NeoGenomics Completes Acquisition of Pathline

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

NeoGenomics Reports First Quarter 2025 Results

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

NeoGenomics Pays Off 1.25% Convertible Senior Notes

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

Amedisys

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

Enhabit

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

National Research Corporation - Common Stock

National Research

Nutex Health

OPKO Health

Performant Healthcare, Inc. - Common Stock

Performant Healthcare

Premier

Pennant Gr

Privia Health Gr

Talkspace

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings

Piper Sandler

Morgan Stanley

Goldman Sachs

Leerink Partners

Needham

Comments

NeoGenomics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell